nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—lung cancer	0.474	1	CbGaD
Salicylate-sodium—PTGS2—Cisplatin—lung cancer	0.0787	0.356	CbGbCtD
Salicylate-sodium—PTGS2—Etoposide—lung cancer	0.0774	0.349	CbGbCtD
Salicylate-sodium—PTGS1—Etoposide—lung cancer	0.0653	0.295	CbGbCtD
Salicylate-sodium—Acetylsalicylic acid—AKR1C1—lung cancer	0.0023	0.293	CrCbGaD
Salicylate-sodium—Salicylic acid—AKR1C1—lung cancer	0.00189	0.241	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—TP53—lung cancer	0.0012	0.153	CrCbGaD
Salicylate-sodium—Magnesium salicylate—PTGS2—lung cancer	0.000369	0.047	CrCbGaD
Salicylate-sodium—Magnesium salicylate—ALB—lung cancer	0.000329	0.0419	CrCbGaD
Salicylate-sodium—Salsalate—PTGS2—lung cancer	0.000314	0.04	CrCbGaD
Salicylate-sodium—Mesalazine—PTGS2—lung cancer	0.000272	0.0347	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—lung cancer	0.000234	0.0298	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—ALB—lung cancer	0.000209	0.0266	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—ABCB1—lung cancer	0.000199	0.0254	CrCbGaD
Salicylate-sodium—Salicylic acid—PTGS2—lung cancer	0.000193	0.0246	CrCbGaD
Salicylate-sodium—Salicylic acid—ALB—lung cancer	0.000172	0.0219	CrCbGaD
Salicylate-sodium—Salicylic acid—ABCB1—lung cancer	0.000164	0.0209	CrCbGaD
Salicylate-sodium—Constipation—Irinotecan—lung cancer	0.000162	0.000661	CcSEcCtD
Salicylate-sodium—Chest pain—Paclitaxel—lung cancer	0.000161	0.000657	CcSEcCtD
Salicylate-sodium—Hypotension—Cisplatin—lung cancer	0.000161	0.000656	CcSEcCtD
Salicylate-sodium—Anxiety—Paclitaxel—lung cancer	0.000161	0.000655	CcSEcCtD
Salicylate-sodium—Erythema—Docetaxel—lung cancer	0.000161	0.000655	CcSEcCtD
Salicylate-sodium—Decreased appetite—Gemcitabine—lung cancer	0.000161	0.000654	CcSEcCtD
Salicylate-sodium—Nausea—Topotecan—lung cancer	0.00016	0.000651	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Methotrexate—lung cancer	0.000159	0.000649	CcSEcCtD
Salicylate-sodium—Fatigue—Gemcitabine—lung cancer	0.000159	0.000649	CcSEcCtD
Salicylate-sodium—Confusional state—Etoposide—lung cancer	0.000159	0.000648	CcSEcCtD
Salicylate-sodium—Pain—Gemcitabine—lung cancer	0.000158	0.000644	CcSEcCtD
Salicylate-sodium—Constipation—Gemcitabine—lung cancer	0.000158	0.000644	CcSEcCtD
Salicylate-sodium—Nausea—Erlotinib—lung cancer	0.000158	0.000644	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Etoposide—lung cancer	0.000158	0.000643	CcSEcCtD
Salicylate-sodium—Diarrhoea—Vinorelbine—lung cancer	0.000157	0.000641	CcSEcCtD
Salicylate-sodium—Dysgeusia—Docetaxel—lung cancer	0.000157	0.000641	CcSEcCtD
Salicylate-sodium—Infection—Etoposide—lung cancer	0.000157	0.000639	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Irinotecan—lung cancer	0.000156	0.000637	CcSEcCtD
Salicylate-sodium—Confusional state—Paclitaxel—lung cancer	0.000156	0.000636	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Doxorubicin—lung cancer	0.000156	0.000636	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Irinotecan—lung cancer	0.000155	0.000632	CcSEcCtD
Salicylate-sodium—Dehydration—Doxorubicin—lung cancer	0.000155	0.000631	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Paclitaxel—lung cancer	0.000155	0.00063	CcSEcCtD
Salicylate-sodium—Oedema—Paclitaxel—lung cancer	0.000155	0.00063	CcSEcCtD
Salicylate-sodium—Paraesthesia—Cisplatin—lung cancer	0.000155	0.00063	CcSEcCtD
Salicylate-sodium—Tachycardia—Etoposide—lung cancer	0.000154	0.000627	CcSEcCtD
Salicylate-sodium—Infection—Paclitaxel—lung cancer	0.000154	0.000626	CcSEcCtD
Salicylate-sodium—Dyspnoea—Cisplatin—lung cancer	0.000154	0.000626	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Etoposide—lung cancer	0.000153	0.000621	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Gemcitabine—lung cancer	0.000152	0.00062	CcSEcCtD
Salicylate-sodium—Shock—Paclitaxel—lung cancer	0.000152	0.00062	CcSEcCtD
Salicylate-sodium—Dizziness—Vinorelbine—lung cancer	0.000152	0.00062	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Doxorubicin—lung cancer	0.000152	0.00062	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Doxorubicin—lung cancer	0.000152	0.000617	CcSEcCtD
Salicylate-sodium—Tachycardia—Paclitaxel—lung cancer	0.000151	0.000615	CcSEcCtD
Salicylate-sodium—Anorexia—Etoposide—lung cancer	0.00015	0.000613	CcSEcCtD
Salicylate-sodium—Body temperature increased—Irinotecan—lung cancer	0.00015	0.000611	CcSEcCtD
Salicylate-sodium—Abdominal pain—Irinotecan—lung cancer	0.00015	0.000611	CcSEcCtD
Salicylate-sodium—Decreased appetite—Cisplatin—lung cancer	0.00015	0.00061	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Paclitaxel—lung cancer	0.00015	0.000609	CcSEcCtD
Salicylate-sodium—Drowsiness—Methotrexate—lung cancer	0.000148	0.000604	CcSEcCtD
Salicylate-sodium—Anorexia—Paclitaxel—lung cancer	0.000148	0.000601	CcSEcCtD
Salicylate-sodium—Hypotension—Etoposide—lung cancer	0.000147	0.000601	CcSEcCtD
Salicylate-sodium—Pain—Cisplatin—lung cancer	0.000147	0.0006	CcSEcCtD
Salicylate-sodium—Vomiting—Vinorelbine—lung cancer	0.000146	0.000596	CcSEcCtD
Salicylate-sodium—Body temperature increased—Gemcitabine—lung cancer	0.000146	0.000595	CcSEcCtD
Salicylate-sodium—Renal failure—Methotrexate—lung cancer	0.000146	0.000593	CcSEcCtD
Salicylate-sodium—Rash—Vinorelbine—lung cancer	0.000145	0.000591	CcSEcCtD
Salicylate-sodium—Dermatitis—Vinorelbine—lung cancer	0.000145	0.00059	CcSEcCtD
Salicylate-sodium—Abdominal distension—Doxorubicin—lung cancer	0.000145	0.00059	CcSEcCtD
Salicylate-sodium—Hypotension—Paclitaxel—lung cancer	0.000145	0.000589	CcSEcCtD
Salicylate-sodium—Headache—Vinorelbine—lung cancer	0.000144	0.000587	CcSEcCtD
Salicylate-sodium—Syncope—Docetaxel—lung cancer	0.000144	0.000587	CcSEcCtD
Salicylate-sodium—Asthma—Doxorubicin—lung cancer	0.000144	0.000586	CcSEcCtD
Salicylate-sodium—Dysphagia—Doxorubicin—lung cancer	0.000144	0.000586	CcSEcCtD
Salicylate-sodium—Palpitations—Docetaxel—lung cancer	0.000142	0.000578	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Cisplatin—lung cancer	0.000142	0.000578	CcSEcCtD
Salicylate-sodium—Paraesthesia—Etoposide—lung cancer	0.000142	0.000577	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Docetaxel—lung cancer	0.000141	0.000575	CcSEcCtD
Salicylate-sodium—Dyspnoea—Etoposide—lung cancer	0.000141	0.000573	CcSEcCtD
Salicylate-sodium—Somnolence—Etoposide—lung cancer	0.00014	0.000571	CcSEcCtD
Salicylate-sodium—Epistaxis—Methotrexate—lung cancer	0.00014	0.000569	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Irinotecan—lung cancer	0.00014	0.000569	CcSEcCtD
Salicylate-sodium—Convulsion—Docetaxel—lung cancer	0.000139	0.000567	CcSEcCtD
Salicylate-sodium—Paraesthesia—Paclitaxel—lung cancer	0.000139	0.000566	CcSEcCtD
Salicylate-sodium—Bronchitis—Doxorubicin—lung cancer	0.000138	0.000564	CcSEcCtD
Salicylate-sodium—Dyspnoea—Paclitaxel—lung cancer	0.000138	0.000562	CcSEcCtD
Salicylate-sodium—Somnolence—Paclitaxel—lung cancer	0.000138	0.00056	CcSEcCtD
Salicylate-sodium—Decreased appetite—Etoposide—lung cancer	0.000137	0.000559	CcSEcCtD
Salicylate-sodium—Chest pain—Docetaxel—lung cancer	0.000137	0.000557	CcSEcCtD
Salicylate-sodium—Nausea—Vinorelbine—lung cancer	0.000137	0.000557	CcSEcCtD
Salicylate-sodium—Dyspepsia—Paclitaxel—lung cancer	0.000136	0.000555	CcSEcCtD
Salicylate-sodium—Body temperature increased—Cisplatin—lung cancer	0.000136	0.000555	CcSEcCtD
Salicylate-sodium—Asthenia—Irinotecan—lung cancer	0.000136	0.000554	CcSEcCtD
Salicylate-sodium—Fatigue—Etoposide—lung cancer	0.000136	0.000554	CcSEcCtD
Salicylate-sodium—Pain—Etoposide—lung cancer	0.000135	0.00055	CcSEcCtD
Salicylate-sodium—Constipation—Etoposide—lung cancer	0.000135	0.00055	CcSEcCtD
Salicylate-sodium—Decreased appetite—Paclitaxel—lung cancer	0.000135	0.000548	CcSEcCtD
Salicylate-sodium—Fatigue—Paclitaxel—lung cancer	0.000133	0.000543	CcSEcCtD
Salicylate-sodium—Hepatitis—Methotrexate—lung cancer	0.000133	0.000542	CcSEcCtD
Salicylate-sodium—Asthenia—Gemcitabine—lung cancer	0.000133	0.00054	CcSEcCtD
Salicylate-sodium—Constipation—Paclitaxel—lung cancer	0.000132	0.000539	CcSEcCtD
Salicylate-sodium—Pain—Paclitaxel—lung cancer	0.000132	0.000539	CcSEcCtD
Salicylate-sodium—Confusional state—Docetaxel—lung cancer	0.000132	0.000539	CcSEcCtD
Salicylate-sodium—Oedema—Docetaxel—lung cancer	0.000131	0.000534	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Docetaxel—lung cancer	0.000131	0.000534	CcSEcCtD
Salicylate-sodium—Weight increased—Doxorubicin—lung cancer	0.000131	0.000534	CcSEcCtD
Salicylate-sodium—Pruritus—Gemcitabine—lung cancer	0.000131	0.000533	CcSEcCtD
Salicylate-sodium—Infection—Docetaxel—lung cancer	0.00013	0.000531	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Etoposide—lung cancer	0.00013	0.00053	CcSEcCtD
Salicylate-sodium—Diarrhoea—Irinotecan—lung cancer	0.00013	0.000529	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Etoposide—lung cancer	0.000129	0.000526	CcSEcCtD
Salicylate-sodium—Shock—Docetaxel—lung cancer	0.000129	0.000526	CcSEcCtD
Salicylate-sodium—Drowsiness—Doxorubicin—lung cancer	0.000128	0.000523	CcSEcCtD
Salicylate-sodium—Tachycardia—Docetaxel—lung cancer	0.000128	0.000521	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Paclitaxel—lung cancer	0.000128	0.000519	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Cisplatin—lung cancer	0.000127	0.000517	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Paclitaxel—lung cancer	0.000127	0.000515	CcSEcCtD
Salicylate-sodium—Diarrhoea—Gemcitabine—lung cancer	0.000126	0.000515	CcSEcCtD
Salicylate-sodium—Renal failure—Doxorubicin—lung cancer	0.000126	0.000514	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Methotrexate—lung cancer	0.000126	0.000512	CcSEcCtD
Salicylate-sodium—Dizziness—Irinotecan—lung cancer	0.000125	0.000511	CcSEcCtD
Salicylate-sodium—Urticaria—Etoposide—lung cancer	0.000125	0.000511	CcSEcCtD
Salicylate-sodium—Anorexia—Docetaxel—lung cancer	0.000125	0.000509	CcSEcCtD
Salicylate-sodium—Abdominal pain—Etoposide—lung cancer	0.000125	0.000508	CcSEcCtD
Salicylate-sodium—Body temperature increased—Etoposide—lung cancer	0.000125	0.000508	CcSEcCtD
Salicylate-sodium—Tinnitus—Methotrexate—lung cancer	0.000124	0.000505	CcSEcCtD
Salicylate-sodium—Asthenia—Cisplatin—lung cancer	0.000124	0.000503	CcSEcCtD
Salicylate-sodium—Urticaria—Paclitaxel—lung cancer	0.000123	0.000501	CcSEcCtD
Salicylate-sodium—Hypotension—Docetaxel—lung cancer	0.000123	0.000499	CcSEcCtD
Salicylate-sodium—Abdominal pain—Paclitaxel—lung cancer	0.000122	0.000498	CcSEcCtD
Salicylate-sodium—Body temperature increased—Paclitaxel—lung cancer	0.000122	0.000498	CcSEcCtD
Salicylate-sodium—Epistaxis—Doxorubicin—lung cancer	0.000121	0.000493	CcSEcCtD
Salicylate-sodium—Vomiting—Irinotecan—lung cancer	0.000121	0.000491	CcSEcCtD
Salicylate-sodium—Rash—Irinotecan—lung cancer	0.00012	0.000487	CcSEcCtD
Salicylate-sodium—Dermatitis—Irinotecan—lung cancer	0.00012	0.000487	CcSEcCtD
Salicylate-sodium—Headache—Irinotecan—lung cancer	0.000119	0.000484	CcSEcCtD
Salicylate-sodium—Diarrhoea—Cisplatin—lung cancer	0.000118	0.00048	CcSEcCtD
Salicylate-sodium—Paraesthesia—Docetaxel—lung cancer	0.000118	0.00048	CcSEcCtD
Salicylate-sodium—Vomiting—Gemcitabine—lung cancer	0.000118	0.000479	CcSEcCtD
Salicylate-sodium—Dyspnoea—Docetaxel—lung cancer	0.000117	0.000476	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—MYC—lung cancer	0.000117	0.00229	CbGpPWpGaD
Salicylate-sodium—Somnolence—Docetaxel—lung cancer	0.000117	0.000475	CcSEcCtD
Salicylate-sodium—Rash—Gemcitabine—lung cancer	0.000117	0.000475	CcSEcCtD
Salicylate-sodium—Dermatitis—Gemcitabine—lung cancer	0.000116	0.000474	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Etoposide—lung cancer	0.000116	0.000474	CcSEcCtD
Salicylate-sodium—Erythema—Methotrexate—lung cancer	0.000116	0.000472	CcSEcCtD
Salicylate-sodium—Headache—Gemcitabine—lung cancer	0.000116	0.000472	CcSEcCtD
Salicylate-sodium—Dyspepsia—Docetaxel—lung cancer	0.000115	0.00047	CcSEcCtD
Salicylate-sodium—Hepatitis—Doxorubicin—lung cancer	0.000115	0.000469	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Doxorubicin—lung cancer	0.000115	0.000467	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	0.000114	0.00224	CbGpPWpGaD
Salicylate-sodium—Decreased appetite—Docetaxel—lung cancer	0.000114	0.000464	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Paclitaxel—lung cancer	0.000114	0.000464	CcSEcCtD
Salicylate-sodium—Dysgeusia—Methotrexate—lung cancer	0.000113	0.000462	CcSEcCtD
Salicylate-sodium—Asthenia—Etoposide—lung cancer	0.000113	0.000461	CcSEcCtD
Salicylate-sodium—Fatigue—Docetaxel—lung cancer	0.000113	0.000461	CcSEcCtD
Salicylate-sodium—Nausea—Irinotecan—lung cancer	0.000113	0.000459	CcSEcCtD
Salicylate-sodium—Constipation—Docetaxel—lung cancer	0.000112	0.000457	CcSEcCtD
Salicylate-sodium—Pain—Docetaxel—lung cancer	0.000112	0.000457	CcSEcCtD
Salicylate-sodium—Pruritus—Etoposide—lung cancer	0.000112	0.000455	CcSEcCtD
Salicylate-sodium—Asthenia—Paclitaxel—lung cancer	0.000111	0.000452	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.00011	0.00216	CbGpPWpGaD
Salicylate-sodium—Nausea—Gemcitabine—lung cancer	0.00011	0.000447	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—ALB—lung cancer	0.00011	0.00215	CbGpPWpGaD
Salicylate-sodium—Vomiting—Cisplatin—lung cancer	0.00011	0.000446	CcSEcCtD
Salicylate-sodium—Pruritus—Paclitaxel—lung cancer	0.000109	0.000446	CcSEcCtD
Salicylate-sodium—Vision blurred—Methotrexate—lung cancer	0.000109	0.000445	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Doxorubicin—lung cancer	0.000109	0.000444	CcSEcCtD
Salicylate-sodium—Rash—Cisplatin—lung cancer	0.000109	0.000442	CcSEcCtD
Salicylate-sodium—Dermatitis—Cisplatin—lung cancer	0.000109	0.000442	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Docetaxel—lung cancer	0.000108	0.00044	CcSEcCtD
Salicylate-sodium—Diarrhoea—Etoposide—lung cancer	0.000108	0.00044	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	0.000108	0.00212	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	0.000108	0.00211	CbGpPWpGaD
Salicylate-sodium—Tinnitus—Doxorubicin—lung cancer	0.000107	0.000438	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Docetaxel—lung cancer	0.000107	0.000437	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CDKN2A—lung cancer	0.000106	0.00209	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Paclitaxel—lung cancer	0.000106	0.000431	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—AZIN2—lung cancer	0.000105	0.00205	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—COL4A3BP—lung cancer	0.000105	0.00205	CbGpPWpGaD
Salicylate-sodium—Dizziness—Etoposide—lung cancer	0.000104	0.000425	CcSEcCtD
Salicylate-sodium—Body temperature increased—Docetaxel—lung cancer	0.000104	0.000422	CcSEcCtD
Salicylate-sodium—Abdominal pain—Docetaxel—lung cancer	0.000104	0.000422	CcSEcCtD
Salicylate-sodium—Arrhythmia—Doxorubicin—lung cancer	0.000103	0.000419	CcSEcCtD
Salicylate-sodium—Dizziness—Paclitaxel—lung cancer	0.000102	0.000417	CcSEcCtD
Salicylate-sodium—Nausea—Cisplatin—lung cancer	0.000102	0.000417	CcSEcCtD
Salicylate-sodium—Convulsion—Methotrexate—lung cancer	0.0001	0.000409	CcSEcCtD
Salicylate-sodium—Vomiting—Etoposide—lung cancer	0.0001	0.000409	CcSEcCtD
Salicylate-sodium—Erythema—Doxorubicin—lung cancer	0.0001	0.000409	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CD4—lung cancer	0.0001	0.00197	CbGpPWpGaD
Salicylate-sodium—Rash—Etoposide—lung cancer	9.95e-05	0.000405	CcSEcCtD
Salicylate-sodium—Dermatitis—Etoposide—lung cancer	9.94e-05	0.000405	CcSEcCtD
Salicylate-sodium—Headache—Etoposide—lung cancer	9.89e-05	0.000403	CcSEcCtD
Salicylate-sodium—Flatulence—Doxorubicin—lung cancer	9.88e-05	0.000403	CcSEcCtD
Salicylate-sodium—Chest pain—Methotrexate—lung cancer	9.86e-05	0.000402	CcSEcCtD
Salicylate-sodium—Vomiting—Paclitaxel—lung cancer	9.84e-05	0.000401	CcSEcCtD
Salicylate-sodium—Dysgeusia—Doxorubicin—lung cancer	9.82e-05	0.0004	CcSEcCtD
Salicylate-sodium—Rash—Paclitaxel—lung cancer	9.76e-05	0.000397	CcSEcCtD
Salicylate-sodium—Dermatitis—Paclitaxel—lung cancer	9.75e-05	0.000397	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	9.75e-05	0.00191	CbGpPWpGaD
Salicylate-sodium—Headache—Paclitaxel—lung cancer	9.7e-05	0.000395	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Docetaxel—lung cancer	9.67e-05	0.000394	CcSEcCtD
Salicylate-sodium—Confusional state—Methotrexate—lung cancer	9.53e-05	0.000388	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Methotrexate—lung cancer	9.45e-05	0.000385	CcSEcCtD
Salicylate-sodium—Vision blurred—Doxorubicin—lung cancer	9.45e-05	0.000385	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	9.44e-05	0.00185	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	9.43e-05	0.00185	CbGpPWpGaD
Salicylate-sodium—Asthenia—Docetaxel—lung cancer	9.41e-05	0.000383	CcSEcCtD
Salicylate-sodium—Infection—Methotrexate—lung cancer	9.39e-05	0.000383	CcSEcCtD
Salicylate-sodium—Nausea—Etoposide—lung cancer	9.38e-05	0.000382	CcSEcCtD
Salicylate-sodium—Pruritus—Docetaxel—lung cancer	9.28e-05	0.000378	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	9.26e-05	0.00182	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—RB1—lung cancer	9.23e-05	0.00181	CbGpPWpGaD
Salicylate-sodium—Nausea—Paclitaxel—lung cancer	9.19e-05	0.000374	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	9.17e-05	0.0018	CbGpPWpGaD
Salicylate-sodium—Hyperhidrosis—Methotrexate—lung cancer	9.14e-05	0.000372	CcSEcCtD
Salicylate-sodium—Anorexia—Methotrexate—lung cancer	9.01e-05	0.000367	CcSEcCtD
Salicylate-sodium—Syncope—Doxorubicin—lung cancer	9e-05	0.000366	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CCND1—lung cancer	9e-05	0.00177	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Docetaxel—lung cancer	8.98e-05	0.000366	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—ATP5H—lung cancer	8.89e-05	0.00174	CbGpPWpGaD
Salicylate-sodium—Palpitations—Doxorubicin—lung cancer	8.86e-05	0.000361	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—POMC—lung cancer	8.86e-05	0.00174	CbGpPWpGaD
Salicylate-sodium—Hypotension—Methotrexate—lung cancer	8.83e-05	0.00036	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Doxorubicin—lung cancer	8.82e-05	0.000359	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CDKN1A—lung cancer	8.7e-05	0.00171	CbGpPWpGaD
Salicylate-sodium—Convulsion—Doxorubicin—lung cancer	8.69e-05	0.000354	CcSEcCtD
Salicylate-sodium—Dizziness—Docetaxel—lung cancer	8.67e-05	0.000353	CcSEcCtD
Salicylate-sodium—Chest pain—Doxorubicin—lung cancer	8.54e-05	0.000348	CcSEcCtD
Salicylate-sodium—Anxiety—Doxorubicin—lung cancer	8.51e-05	0.000347	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	8.51e-05	0.00167	CbGpPWpGaD
Salicylate-sodium—Paraesthesia—Methotrexate—lung cancer	8.49e-05	0.000346	CcSEcCtD
Salicylate-sodium—Dyspnoea—Methotrexate—lung cancer	8.43e-05	0.000343	CcSEcCtD
Salicylate-sodium—Somnolence—Methotrexate—lung cancer	8.41e-05	0.000342	CcSEcCtD
Salicylate-sodium—Vomiting—Docetaxel—lung cancer	8.34e-05	0.00034	CcSEcCtD
Salicylate-sodium—Dyspepsia—Methotrexate—lung cancer	8.32e-05	0.000339	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—AZIN2—lung cancer	8.3e-05	0.00163	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—COL4A3BP—lung cancer	8.3e-05	0.00163	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—EP300—lung cancer	8.28e-05	0.00162	CbGpPWpGaD
Salicylate-sodium—Rash—Docetaxel—lung cancer	8.27e-05	0.000337	CcSEcCtD
Salicylate-sodium—Dermatitis—Docetaxel—lung cancer	8.26e-05	0.000337	CcSEcCtD
Salicylate-sodium—Confusional state—Doxorubicin—lung cancer	8.26e-05	0.000336	CcSEcCtD
Salicylate-sodium—Decreased appetite—Methotrexate—lung cancer	8.22e-05	0.000335	CcSEcCtD
Salicylate-sodium—Headache—Docetaxel—lung cancer	8.22e-05	0.000335	CcSEcCtD
Salicylate-sodium—Oedema—Doxorubicin—lung cancer	8.19e-05	0.000333	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Doxorubicin—lung cancer	8.19e-05	0.000333	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	8.17e-05	0.0016	CbGpPWpGaD
Salicylate-sodium—Fatigue—Methotrexate—lung cancer	8.15e-05	0.000332	CcSEcCtD
Salicylate-sodium—Infection—Doxorubicin—lung cancer	8.13e-05	0.000331	CcSEcCtD
Salicylate-sodium—Pain—Methotrexate—lung cancer	8.09e-05	0.000329	CcSEcCtD
Salicylate-sodium—Shock—Doxorubicin—lung cancer	8.05e-05	0.000328	CcSEcCtD
Salicylate-sodium—Tachycardia—Doxorubicin—lung cancer	7.99e-05	0.000325	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—PLBD1—lung cancer	7.92e-05	0.00155	CbGpPWpGaD
Salicylate-sodium—Hyperhidrosis—Doxorubicin—lung cancer	7.91e-05	0.000322	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	7.83e-05	0.00154	CbGpPWpGaD
Salicylate-sodium—Anorexia—Doxorubicin—lung cancer	7.8e-05	0.000318	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	7.79e-05	0.00153	CbGpPWpGaD
Salicylate-sodium—Nausea—Docetaxel—lung cancer	7.79e-05	0.000317	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Methotrexate—lung cancer	7.79e-05	0.000317	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—NRAS—lung cancer	7.75e-05	0.00152	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	7.74e-05	0.00152	CbGpPWpGaD
Salicylate-sodium—Gastrointestinal pain—Methotrexate—lung cancer	7.73e-05	0.000315	CcSEcCtD
Salicylate-sodium—Hypotension—Doxorubicin—lung cancer	7.65e-05	0.000312	CcSEcCtD
Salicylate-sodium—Urticaria—Methotrexate—lung cancer	7.51e-05	0.000306	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	7.49e-05	0.00147	CbGpPWpGaD
Salicylate-sodium—Body temperature increased—Methotrexate—lung cancer	7.47e-05	0.000304	CcSEcCtD
Salicylate-sodium—Abdominal pain—Methotrexate—lung cancer	7.47e-05	0.000304	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CXCL8—lung cancer	7.36e-05	0.00144	CbGpPWpGaD
Salicylate-sodium—Paraesthesia—Doxorubicin—lung cancer	7.35e-05	0.000299	CcSEcCtD
Salicylate-sodium—Dyspnoea—Doxorubicin—lung cancer	7.3e-05	0.000297	CcSEcCtD
Salicylate-sodium—Somnolence—Doxorubicin—lung cancer	7.28e-05	0.000296	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—HSD17B10—lung cancer	7.25e-05	0.00142	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—MYC—lung cancer	7.22e-05	0.00142	CbGpPWpGaD
Salicylate-sodium—Dyspepsia—Doxorubicin—lung cancer	7.21e-05	0.000293	CcSEcCtD
Salicylate-sodium—Decreased appetite—Doxorubicin—lung cancer	7.12e-05	0.00029	CcSEcCtD
Salicylate-sodium—Fatigue—Doxorubicin—lung cancer	7.06e-05	0.000287	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—ATP5H—lung cancer	7.06e-05	0.00138	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CASP3—lung cancer	7.04e-05	0.00138	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL2—lung cancer	7.03e-05	0.00138	CbGpPWpGaD
Salicylate-sodium—Constipation—Doxorubicin—lung cancer	7e-05	0.000285	CcSEcCtD
Salicylate-sodium—Pain—Doxorubicin—lung cancer	7e-05	0.000285	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Methotrexate—lung cancer	6.97e-05	0.000284	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CCND1—lung cancer	6.85e-05	0.00135	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—APC—lung cancer	6.8e-05	0.00133	CbGpPWpGaD
Salicylate-sodium—Asthenia—Methotrexate—lung cancer	6.78e-05	0.000276	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Doxorubicin—lung cancer	6.75e-05	0.000275	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—CKB—lung cancer	6.74e-05	0.00132	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	6.72e-05	0.00132	CbGpPWpGaD
Salicylate-sodium—Gastrointestinal pain—Doxorubicin—lung cancer	6.69e-05	0.000273	CcSEcCtD
Salicylate-sodium—Pruritus—Methotrexate—lung cancer	6.69e-05	0.000272	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—KRAS—lung cancer	6.67e-05	0.00131	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MMP9—lung cancer	6.65e-05	0.00131	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL6—lung cancer	6.58e-05	0.00129	CbGpPWpGaD
Salicylate-sodium—Urticaria—Doxorubicin—lung cancer	6.5e-05	0.000265	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	6.49e-05	0.00127	CbGpPWpGaD
Salicylate-sodium—Abdominal pain—Doxorubicin—lung cancer	6.47e-05	0.000264	CcSEcCtD
Salicylate-sodium—Body temperature increased—Doxorubicin—lung cancer	6.47e-05	0.000264	CcSEcCtD
Salicylate-sodium—Diarrhoea—Methotrexate—lung cancer	6.47e-05	0.000263	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—CNDP2—lung cancer	6.33e-05	0.00124	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTM2—lung cancer	6.33e-05	0.00124	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	6.33e-05	0.00124	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	6.3e-05	0.00124	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PLBD1—lung cancer	6.29e-05	0.00123	CbGpPWpGaD
Salicylate-sodium—Dizziness—Methotrexate—lung cancer	6.25e-05	0.000255	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	6.19e-05	0.00121	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MTMR3—lung cancer	6.16e-05	0.00121	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Doxorubicin—lung cancer	6.03e-05	0.000246	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	6.01e-05	0.00118	CbGpPWpGaD
Salicylate-sodium—Vomiting—Methotrexate—lung cancer	6.01e-05	0.000245	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—PGAM1—lung cancer	6e-05	0.00118	CbGpPWpGaD
Salicylate-sodium—Rash—Methotrexate—lung cancer	5.96e-05	0.000243	CcSEcCtD
Salicylate-sodium—Dermatitis—Methotrexate—lung cancer	5.96e-05	0.000243	CcSEcCtD
Salicylate-sodium—Headache—Methotrexate—lung cancer	5.92e-05	0.000241	CcSEcCtD
Salicylate-sodium—Asthenia—Doxorubicin—lung cancer	5.87e-05	0.000239	CcSEcCtD
Salicylate-sodium—Pruritus—Doxorubicin—lung cancer	5.79e-05	0.000236	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—HSD17B10—lung cancer	5.75e-05	0.00113	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP2A7—lung cancer	5.73e-05	0.00112	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PGAM1—lung cancer	5.69e-05	0.00112	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—HRAS—lung cancer	5.67e-05	0.00111	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MAPK3—lung cancer	5.65e-05	0.00111	CbGpPWpGaD
Salicylate-sodium—Nausea—Methotrexate—lung cancer	5.62e-05	0.000229	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—SDC4—lung cancer	5.61e-05	0.0011	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Doxorubicin—lung cancer	5.6e-05	0.000228	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MYC—lung cancer	5.5e-05	0.00108	CbGpPWpGaD
Salicylate-sodium—Dizziness—Doxorubicin—lung cancer	5.41e-05	0.00022	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—EGFR—lung cancer	5.38e-05	0.00106	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	5.35e-05	0.00105	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CKB—lung cancer	5.35e-05	0.00105	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	5.33e-05	0.00105	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SDC4—lung cancer	5.31e-05	0.00104	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	5.28e-05	0.00104	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL6—lung cancer	5.23e-05	0.00103	CbGpPWpGaD
Salicylate-sodium—Vomiting—Doxorubicin—lung cancer	5.21e-05	0.000212	CcSEcCtD
Salicylate-sodium—Rash—Doxorubicin—lung cancer	5.16e-05	0.00021	CcSEcCtD
Salicylate-sodium—Dermatitis—Doxorubicin—lung cancer	5.16e-05	0.00021	CcSEcCtD
Salicylate-sodium—Headache—Doxorubicin—lung cancer	5.13e-05	0.000209	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—RRM1—lung cancer	5.11e-05	0.001	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTA3—lung cancer	5.11e-05	0.001	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CNDP2—lung cancer	5.03e-05	0.000987	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTM2—lung cancer	5.03e-05	0.000987	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MTMR3—lung cancer	4.89e-05	0.00096	CbGpPWpGaD
Salicylate-sodium—Nausea—Doxorubicin—lung cancer	4.86e-05	0.000198	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—B4GALT5—lung cancer	4.8e-05	0.000942	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	4.79e-05	0.00094	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PGAM1—lung cancer	4.77e-05	0.000935	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SKI—lung cancer	4.69e-05	0.00092	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTA4—lung cancer	4.67e-05	0.000916	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	4.66e-05	0.000915	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	4.65e-05	0.000913	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	4.56e-05	0.000896	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTA2—lung cancer	4.55e-05	0.000893	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—B4GALT5—lung cancer	4.55e-05	0.000893	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP2A7—lung cancer	4.55e-05	0.000892	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TP53—lung cancer	4.51e-05	0.000886	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	4.51e-05	0.000885	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	4.5e-05	0.000883	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SDC4—lung cancer	4.45e-05	0.000873	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTA1—lung cancer	4.39e-05	0.000862	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCC3—lung cancer	4.34e-05	0.000852	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	4.29e-05	0.000842	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AKR1C1—lung cancer	4.2e-05	0.000825	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	4.17e-05	0.000819	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL6—lung cancer	4.13e-05	0.000811	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—UGT1A1—lung cancer	4.08e-05	0.000801	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PXN—lung cancer	4.07e-05	0.000799	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	4.06e-05	0.000798	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—RRM1—lung cancer	4.05e-05	0.000795	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTA3—lung cancer	4.05e-05	0.000795	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKR1C1—lung cancer	3.99e-05	0.000782	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GNG11—lung cancer	3.94e-05	0.000772	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.92e-05	0.000768	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	3.85e-05	0.000755	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—B4GALT5—lung cancer	3.81e-05	0.000748	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALDOA—lung cancer	3.75e-05	0.000735	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	3.74e-05	0.000734	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTA4—lung cancer	3.71e-05	0.000728	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NPPA—lung cancer	3.67e-05	0.00072	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	3.66e-05	0.000718	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NCOA3—lung cancer	3.64e-05	0.000714	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.62e-05	0.000711	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTA2—lung cancer	3.61e-05	0.000709	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PPIA—lung cancer	3.58e-05	0.000703	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.58e-05	0.000702	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ALDOA—lung cancer	3.55e-05	0.000697	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCG2—lung cancer	3.54e-05	0.000695	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ADCY1—lung cancer	3.54e-05	0.000695	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTA1—lung cancer	3.49e-05	0.000684	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HPGDS—lung cancer	3.47e-05	0.000681	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ENO2—lung cancer	3.47e-05	0.000681	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	3.46e-05	0.000678	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PPP2R1B—lung cancer	3.45e-05	0.000677	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCC3—lung cancer	3.45e-05	0.000676	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.4e-05	0.000668	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTT1—lung cancer	3.37e-05	0.000661	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ADCY1—lung cancer	3.35e-05	0.000658	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AKR1C1—lung cancer	3.34e-05	0.000655	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GCLC—lung cancer	3.33e-05	0.000653	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP2A6—lung cancer	3.33e-05	0.000653	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.31e-05	0.00065	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ENO2—lung cancer	3.29e-05	0.000646	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PPP2R1B—lung cancer	3.27e-05	0.000642	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SMARCA4—lung cancer	3.27e-05	0.000642	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—UGT1A1—lung cancer	3.24e-05	0.000636	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	3.17e-05	0.000623	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ENO1—lung cancer	3.15e-05	0.000619	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.14e-05	0.000617	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GNG11—lung cancer	3.12e-05	0.000613	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.11e-05	0.00061	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.1e-05	0.000609	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	3.07e-05	0.000603	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ENO1—lung cancer	2.99e-05	0.000587	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALDOA—lung cancer	2.97e-05	0.000584	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NCOA3—lung cancer	2.89e-05	0.000567	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.84e-05	0.000557	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP2E1—lung cancer	2.83e-05	0.000555	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ADCY1—lung cancer	2.81e-05	0.000551	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCG2—lung cancer	2.81e-05	0.000551	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NQO1—lung cancer	2.8e-05	0.000549	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APP—lung cancer	2.78e-05	0.000546	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGF9—lung cancer	2.76e-05	0.000541	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ENO2—lung cancer	2.76e-05	0.000541	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HPGDS—lung cancer	2.76e-05	0.000541	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.74e-05	0.000538	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PPP2R1B—lung cancer	2.74e-05	0.000537	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.71e-05	0.000533	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.7e-05	0.00053	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTT1—lung cancer	2.67e-05	0.000524	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP2A6—lung cancer	2.64e-05	0.000518	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GCLC—lung cancer	2.64e-05	0.000518	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—JUNB—lung cancer	2.63e-05	0.000517	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.63e-05	0.000516	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.59e-05	0.000509	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—STK11—lung cancer	2.52e-05	0.000495	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ENO1—lung cancer	2.5e-05	0.000491	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.49e-05	0.00049	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.46e-05	0.000483	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.37e-05	0.000465	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTP1—lung cancer	2.33e-05	0.000458	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FOXO3—lung cancer	2.31e-05	0.000453	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CAT—lung cancer	2.27e-05	0.000446	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.26e-05	0.000443	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP2E1—lung cancer	2.25e-05	0.000441	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NQO1—lung cancer	2.22e-05	0.000436	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCB1—lung cancer	2.21e-05	0.000433	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.17e-05	0.000427	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—TYMS—lung cancer	2.17e-05	0.000426	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTM1—lung cancer	2.14e-05	0.000421	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HES1—lung cancer	2.04e-05	0.000401	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP1A1—lung cancer	2.03e-05	0.000399	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ERCC2—lung cancer	2.02e-05	0.000396	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—STK11—lung cancer	2e-05	0.000393	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ERCC2—lung cancer	1.91e-05	0.000375	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.88e-05	0.000369	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ERBB3—lung cancer	1.87e-05	0.000367	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTP1—lung cancer	1.85e-05	0.000364	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CAT—lung cancer	1.8e-05	0.000354	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.79e-05	0.000352	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TERT—lung cancer	1.79e-05	0.000352	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCB1—lung cancer	1.75e-05	0.000344	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—APOA1—lung cancer	1.74e-05	0.000342	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGFR1—lung cancer	1.74e-05	0.000341	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—TYMS—lung cancer	1.72e-05	0.000338	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HIF1A—lung cancer	1.71e-05	0.000336	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTM1—lung cancer	1.7e-05	0.000334	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.67e-05	0.000328	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APOA1—lung cancer	1.65e-05	0.000324	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP1A1—lung cancer	1.61e-05	0.000317	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ERCC2—lung cancer	1.6e-05	0.000314	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CG—lung cancer	1.59e-05	0.000312	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—POMC—lung cancer	1.52e-05	0.000297	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APC—lung cancer	1.51e-05	0.000296	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—KIT—lung cancer	1.51e-05	0.000296	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EGF—lung cancer	1.49e-05	0.000293	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CREBBP—lung cancer	1.48e-05	0.00029	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—BRAF—lung cancer	1.42e-05	0.000278	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6R—lung cancer	1.4e-05	0.000275	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CD—lung cancer	1.4e-05	0.000275	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CREBBP—lung cancer	1.4e-05	0.000275	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—APOA1—lung cancer	1.38e-05	0.000272	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALB—lung cancer	1.38e-05	0.000271	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MAP2K1—lung cancer	1.34e-05	0.000262	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3CD—lung cancer	1.33e-05	0.00026	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.33e-05	0.00026	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CG—lung cancer	1.26e-05	0.000248	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CB—lung cancer	1.22e-05	0.000239	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTGS2—lung cancer	1.21e-05	0.000237	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—POMC—lung cancer	1.2e-05	0.000236	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MDM2—lung cancer	1.19e-05	0.000233	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RAF1—lung cancer	1.18e-05	0.000232	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CREBBP—lung cancer	1.17e-05	0.00023	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ERBB2—lung cancer	1.17e-05	0.00023	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MTOR—lung cancer	1.16e-05	0.000227	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3CB—lung cancer	1.16e-05	0.000227	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CD4—lung cancer	1.15e-05	0.000227	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CD—lung cancer	1.11e-05	0.000218	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALB—lung cancer	1.1e-05	0.000215	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTEN—lung cancer	1.05e-05	0.000207	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—EP300—lung cancer	1.01e-05	0.000197	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDKN1A—lung cancer	1e-05	0.000197	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PTEN—lung cancer	9.99e-06	0.000196	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CB—lung cancer	9.68e-06	0.00019	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EP300—lung cancer	9.53e-06	0.000187	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SRC—lung cancer	9.27e-06	0.000182	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—STAT3—lung cancer	8.94e-06	0.000175	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NRAS—lung cancer	8.92e-06	0.000175	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MAPK3—lung cancer	8.54e-06	0.000168	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PTEN—lung cancer	8.37e-06	0.000164	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MYC—lung cancer	8.3e-06	0.000163	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EGFR—lung cancer	8.12e-06	0.000159	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—EP300—lung cancer	7.98e-06	0.000157	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—KRAS—lung cancer	7.67e-06	0.000151	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CA—lung cancer	7.44e-06	0.000146	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3CA—lung cancer	7.05e-06	0.000138	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HRAS—lung cancer	6.52e-06	0.000128	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6—lung cancer	6.24e-06	0.000123	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AKT1—lung cancer	6.08e-06	0.000119	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CA—lung cancer	5.9e-06	0.000116	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKT1—lung cancer	5.76e-06	0.000113	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AKT1—lung cancer	4.82e-06	9.46e-05	CbGpPWpGaD
